chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sick; high fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) and PYREXIA (high fever) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced PYREXIA (high fever). On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) and PYREXIA (high fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Severe rash appeared on right knee 24 hours after the 2nd vaccine.  Red, raised bumps in a crescent pattern. Very itchy.  Did not clear up with Steriod IM shot.  Triamcinolone made it worse.  Ice compresses only thing that helped.  Dermatologist biopsy was folliculitis.  On December 21, went back to dermatologist because it was spreading.  Giving Doxycycline 200mg PO x 14 days, Clobetasol & Exelderm 1% Solution.  Rash started to clear up after 3 days.  Still discoloration on the knee where it was the most severe.  Rash still is unknown in origin.
1st event-3/5/21:  normal workday activity, became short of breath with a constricting feeling and not able to take a deep breath.  pulse elevated, blood pressure elevated. sweaty and lightheaded.  after focused deep breathing, all resolved to normal. 2nd event-7/13/21:  workday activity included  work-inventorying and moving supplies and equipment; after a normal paced walk and normal speaking the same SOB with constriction and not able to take a deep breath.  elevated pulse, tachycardia, elevated blood pressure, sweaty and lightheaded.  after focused deep breathing, return to normal
Tinnitus - dramatic increase.  Prior to vaccine I had mild tinnitus in one ear., a mild dull hissing .  Afterwards , tinnitus occurs in both ears,and now includes high pitched ringing and extra loud hissing.
Its been more than 2 weeks since my vaccine and I still feel extremely fatigued, flu like, stuffy nose in the mornings. Left breast and underarm still feels a little larger than my right side. Still have itching and 1-2 hives around my abdomen and now 1 on my right wrist.
Myalgia & NauseaVomiting Narrative: Chills, nausea, sore, fatigue, muscle aches
I now have iih and papilledema of the eyes. Been nausea-vomiting-sick all the time. Hardly getting out of bed. Had spinal tap 1 and have to get another.
Patient having flu-like symptoms (body aches, fever 101 degrees, chills, malaise)
Sick to stomach; Back pain that spread to knees, feel, heels, and ankles; Back pain that spread to knees, feel, heels, and ankles; Back pain that spread to knees, feel, heels, and ankles; Chills; Lost 12 pounds; This case was reported by a consumer via call center representative and described the occurrence of back pain in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 29th September 2019, less than a day after receiving Shingrix, the patient experienced chills and weight loss. On 30th September 2019, the patient experienced back pain, foot pain and knee pain. In October 2019, the patient experienced stomach discomfort. On an unknown date, the outcome of the back pain, foot pain, knee pain and weight loss were not recovered/not resolved and the outcome of the chills was resolved with sequelae and the outcome of the stomach discomfort was unknown.   It was unknown if the reporter considered the back pain, foot pain, knee pain, chills, weight loss and stomach discomfort to be related to Shingrix.  Additional details were provided as follows: The patient reported for himself. The patient started having back pain that spread to his knees, feet, heels and ankles and had chills. He stated, this pain was ongoing and had progressed.  He also stated, he had been sick to his stomach since three days after the vaccine and lost 12 pounds of weight. Emergency room visit was required. The patient consented to follow up.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 11-FEB-2014 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 15-APR-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster. On or about 15-JUL-2016, the patient sought subsequent treatment for ongoing and worsening outbreaks of shingles infections, requiring increasing regimens of antivirals to manage his symptoms. The patient was prescribed VALTREX for management of his painful and persistent symptoms, and will need to take VALTREX indefinitely to prevent recurrent outbreaks. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a 83-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was the reporter's mother. The age at vaccination was unknown. The reporter stated that the patient never had shingles in her life. The patient got the shingles shot and got shingles and suffered horribly. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not be possible as no contact details were available.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 15-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength: 0.5ml) (lot # L036245, expiration date 09-FEB-2018). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion for three times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer) (R/F) for the first and second time were 16, 29 and R; 176, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer) (R/F) for the third time were 24, 49 and R. The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
Jynneos was administered intradermally; Case reference number US-BN-2022-004329 is a spontaneous case received from a consumer on 21-Oct-2022 via Agency (reference number: USBAV22-1756) and concerns a 39-year-old male patient.  The patient's medical history was not provided. The patient's concomitant medications included fluvic acid and COVID-19 vaccine.  On an unspecified date in Aug-2022, the patient was vaccinated with the first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: unknown), at unknown dose, administered subcutaneously, for monkeypox prophylaxis.  On 20-Oct-2022, the patient was vaccinated with the second dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: unknown), at unknown dose, administered intradermally (explicitly coded as 'Intradermal injection'), for monkeypox prophylaxis.  At the time of this report, it was unknown if the patient experienced any adverse events due to Jynneos vaccination.   Additional information received on 21-Oct-2022 from Bavarian Nordic included local BN case ID.; Reporter's Comments: A 39-year-old male patient was vaccinated with the second dose of Jynneos vaccine, at unknown dose, administered intradermally, which is considered as intradermal injection, for monkeypox prophylaxis. At the time of this report, it was unknown if the patient experienced any adverse events due to Jynneos vaccination. Intradermal injection is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included fluvic acid and COVID-19 vaccine. Intradermal injection has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 39-year-old male patient was vaccinated with the second dose of Jynneos vaccine, at unknown dose, administered intradermally, which is considered as intradermal injection, for monkeypox prophylaxis. At the time of this report, it was unknown if the patient experienced any adverse events due to Jynneos vaccination. Intradermal injection is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included fluvic acid and COVID-19 vaccine. Intradermal injection has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2022 at 9:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2022 at 9:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06 Feb 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient ethnicity reported. No concomitant medications were reported. Patient received booster dose.Vaccine administration time was reported as 09:30:09. No treatment medications were reported.
This spontaneous report as received from a registered nurse refers to a patient of unspecified age ("between 18 and 24 years old"). On an unknown date the patient was vaccinated subcutaneously with an expired dose of 0.5 ml M-M-R II (lot # 669672/0155AA, expiry date 01-FEB-2013). No adverse effects reported. The patient sought medical attention via office visit. Additional information has been requested.
Approximately two weeks after the vaccine had been given, began increase in blood pressure. Still elevated, ARPN prescribed Lisinoprol 2.5 mg, on December 1, 2021, to help lower the BP. Partially worked but still in the range of 140s, compared to mainly `120 with Terazosin. Now Terazosin and  Lisinoprol 2.5 mg taken at night. Today a lowering of the BP appears to have started. At 12.30pm it had dropped to 125/63, pulse 68, taken again while filling out form, slightly higher at 3;40 pm, 131/71 pulse 51. It was recommended I see a cariologist, appointment made, but not available until Februay 2, 2022. Hopefully the Lisinoprol 2.5 mg will help keep the BP at acceptable levels for my age of 85.
Starting approximately 2 hours after administration, patient states arm he received vaccine in went numb. Since numbness has subsided, arm has been in excruciating pain. Patient also felt "woozy".
2 days with fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (2 days with fever) in a 68-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS5051C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jan-2023, the patient experienced PYREXIA (2 days with fever). On 20-Jan-2023, PYREXIA (2 days with fever) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   The number was reported. Concomitant medications were not reported.  No treatment information was provided by the reporter.
No adverse event; HCP calling to report an AE regarding the VARIVAX vaccine. HCP reported that the patient received an expired dose of VARIVAX. Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.; This spontaneous report was received from Consumer and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, lot #U015686, expiration date: 18-MAY-2023 (strength, route of administration, and indication were not provided).  On 06-JUN-2023, HCP called to report an AE regarding the varicella virus vaccine live (oka/merck) (VARIVAX) vaccine. HCP reported that the patient received an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX). Request case 02402383 filed. Permission was provided to contact the HCP. No additional AE/PQC reported.
had shot still got shingles/Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shot still got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles).The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that he/she had been there done that had the shingles shot and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Nurse reported temperature excursion with GARDASIL 9 and VAQTA.; This spontaneous report as received from a Registered Nurse referring to a 17 year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 15-DEC-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 milliliter (strength, route, frequency, and anatomical location were unknown) with lot # 1637641 and expiration date on 16-FEB-2022; and finally with an improperly stored dose of Hepatitis A Vaccine, Inactivated(VAQTA) 0.5 milliliter (strength, route, frequency, and anatomical location were unknown) with lot # T013204 and expiration date on 03-DEC-2021 for prophylaxis.    The administered doses of vaccines experienced temperature excursion (0.38 degrees Celsius) for 4 hours and 45 minutes and (11.09 degrees Celsius) for 1 hour and 30 minutes. There was a digital data logger invloved, but no previous temperature excursion for Hepatitis A Vaccine, Inactivated(VAQTA) but there was a previous temperature excursion with  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (17.52  degrees Celsius) for 2 hours and 42 minutes.
Follow 1st injection of Pfizer, he woke the following morning with a headache which has persisted since - almost 7 weeks.  He has treated it with Aleve daily, with some improvement but the headache never goes away.    He had a phone visit with his physician today.   Medication has been prescribed, which he will pick at the pharmacy today.   His physician plans to see him in office if the medication does not stop the headache.
almost killed me, right hand is paralyzed; almost killed me, right hand is paralyzed; cant walk; in pain; muscles hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Blood transfusions" (unspecified if ongoing), notes: Had two blood transfusions. The patient's concomitant medications were not reported. The following information was reported: PARALYSIS (hospitalization, medically significant, life threatening), BRIEF RESOLVED UNEXPLAINED EVENT (hospitalization, medically significant, life threatening), outcome "unknown" and all described as "almost killed me, right hand is paralyzed"; WALKING DISABILITY (hospitalization), outcome "unknown", described as "cant walk"; PAIN (hospitalization), outcome "unknown", described as "in pain"; MYALGIA (hospitalization), outcome "unknown", described as "muscles hurt". Clinical information: Patient reported that Pfizer I took your vaccine and it almost killed me, my right hand is paralyzed. I can't walk, I am in pain 24/7 all of my muscles hurt. This started with the first injection. Soon I couldn't walk. The pain is unbearable. I am in prison in (state name) at (facility name). They don't know what to do for me. They hope it will go away, it has gotten a lot worse both hands my back. I had two blood transfusion. I am out of ICU and back at the prison under close watch, I am fighting this with all my prayers. I hope that you will help me to live with this monster or get rid of it.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
seizure > 30 minutes, needed multiple medications to stop 11/10/08-records received for DOS 10/15-10/17/2008-DC DX:Seizure associated with fever. Day after receiving vaccines developed twitching of right arm that progressed to bilateral arm and leg twitching and then all over body twitching. Fever on arrival.
Muscles pain, headache, night chills, night sweats, body aches. All symptoms happened on the night of and the day and night after the second dose of vaccine was given. Took,  Ibuprofen each night.
Pt began experiencing hives approximately one week after injections. Symptoms were intermittent over 2 days, then began having angioedema. Presented to our office for examinations. Pt treated with Prednisone, Zyrtec and Zantac. Has not had recurrence since then.
Acute on chronic systolic congestive heart failure; PVC's (premature ventricular contractions); SOB (shortness of breath)
She began itching within 5 minutes of 2nd dose. Given Benadryl. She went home and later in the evening took another dose.  She did not have shortness of breath or swelling of lips, tongue or throat. Itching worst on her neck.  Next day her itching has resolved.  She now has expected side effects of myalgias, headache and fatigue
flu; sick; Based on the additional information received on 08-Oct-2020, the case was initially assessed as non-valid was amended to valid since the suspect vaccine was incorrectly selected as Sanofi Product NOs in the initial version.    Initial information received on 02-Oct-2020 regarding an unsolicited non-valid non-serious social media case through global digital media received from a consumer (Patient).  This case is linked to case 2020SA297232, 2020SA297338, 2020SA297344, 2020SA297203, 2020SA297183, 2020SA297189, 2020SA297215, 2020SA297267, 2020SA297198, 2020SA297259, 2020SA297264, 2020SA297224, 2020SA297197, 2020SA297275, 2020SA297193, 2020SA297278, 2020SA297301, 2020SA297294, 2020SA295993, 2020SA290234, 2020SA285105, 2020SA289150, 2020SA297267 and 2020SA297164 (same source, cluster)  This case involved a 17 years old patient of unknown gender who was sick for two weeks (illness) with flu (influenza) while patient had received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.  On an unknown date in 1969, the patient had a blood test done and the doctor said that the patient needed to be vaccinated with the flu vaccine.   On an unknown date in 1969, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiry date not reported via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date in 1969, reported 3 days post-vaccination the patient was sick (illness) due to flu (influenza) for two weeks. The patient also said that since then the patient had never received the INFLUENZA VACCINE again and thus never suffered from flu also.   It was not reported if the patient received a corrective treatment.  The event outcome was resolved at the time of reporting.  There will be no information available on the batch number for this case.  Additional information received on 08-Oct-2020.   The case amended as valid as company suspect product was added. new event flu was added. The lowest level term coding for event sickness was amended. Age of the patient was updated. the year of vaccination and the year of event was also updated. The event outcome was updated to recovered.   Corresponding fields and narrative updated accordingly.
I started feeling a great deal of pain in my upper right shoulder where I receive the flu shot prior. My right shoulder was aching & it was lumpy and swollen with fluid. Saw my doctor on Nov. 14, 2016 & on Nov. 21, 2016 for the pain.